Our analysis using the TCGA database revealed that EZH2 and MYC were upregulated across multiple human tumors, including stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), and rectum adenocarcinoma (READ) (Figure S7A, Supporting Information). The gene discussed is EZH2; the disease is colon adenocarcinoma.